Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal”

428 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 428 results

Early research (Phase 1)Study completedNCT01889836
What this trial is testing

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Who this might be right for
Meningitis, Meningococcal, Serogroup C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 60
Large-scale testing (Phase 3)Study completedNCT06011200
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Who this might be right for
Epidemic Meningitis
CanSino Biologics Inc. 1,000
Early research (Phase 1)Study completedNCT05739292
What this trial is testing

Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old

Who this might be right for
Infection, Meningococcal
EuBiologics Co.,Ltd 60
Not applicableStudy completedNCT04665791
What this trial is testing

A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults

Who this might be right for
Meningitis, Meningococcal
Center for Vaccine Development - Mali 55
Large-scale testing (Phase 3)Study completedNCT00974363
What this trial is testing

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 697
Early research (Phase 1)Looking for participantsNCT07395739
What this trial is testing

A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104

Who this might be right for
Neisseria Meningitidis Serogroup B
Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) 30
Large-scale testing (Phase 3)Study completedNCT02842853
What this trial is testing

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 3,344
Large-scale testing (Phase 3)Study completedNCT01839175
What this trial is testing

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
Sanofi Pasteur, a Sanofi Company 350
Not applicableLooking for participantsNCT07379151
What this trial is testing

Evaluation of the Antibody Persistence Beyond Five Years After Immunization With MenFiveTM (NmCV-5), a Pentavalent Meningococcal ACYWX Conjugate Vaccine

Who this might be right for
Meningoccocal Disease
Serum Institute of India Pvt. Ltd. 450
Large-scale testing (Phase 3)Study completedNCT00474487
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
Novartis Vaccines 2,831
Post-approval studies (Phase 4)Study completedNCT00310713
What this trial is testing

Persistence of Antibodies and Kinetics of B Cell Response in Healthy Children After Vaccination With MCC Vaccine

Who this might be right for
Prevention of Meningococcal Infection
Novartis Vaccines 33
Large-scale testing (Phase 3)Study completedNCT03476135
What this trial is testing

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

Who this might be right for
Meningococcal Infections
Sanofi Pasteur, a Sanofi Company 91
Testing effectiveness (Phase 2)Study completedNCT00715910
What this trial is testing

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 818
Large-scale testing (Phase 3)Study completedNCT00856297
What this trial is testing

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 389
Large-scale testing (Phase 3)Study completedNCT00514904
What this trial is testing

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

Who this might be right for
Infections, MeningococcalMeningococcal Vaccines
GlaxoSmithKline 1,504
Large-scale testing (Phase 3)Study completedNCT01428908
What this trial is testing

Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children

Who this might be right for
Group A, C Polysaccharide MeningitisType b Haemophilus Influenza
Jiangsu Province Centers for Disease Control and Prevention 2,394
Large-scale testing (Phase 3)Study completedNCT01900899
What this trial is testing

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Who this might be right for
Infections, Meningococcal
Pfizer 184
Large-scale testing (Phase 3)Study completedNCT01340898
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

Who this might be right for
Meningococcal Infection
GlaxoSmithKline 753
Large-scale testing (Phase 3)Active Not RecruitingNCT06226714
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

Who this might be right for
Meningococcal Meningitis
CanSino Biologics Inc. 840
Early research (Phase 1)Study completedNCT01640652
What this trial is testing

MenPF-1 - A New Vaccine Against Meningococcal Disease

Who this might be right for
Serogroup B Meningococcal Disease
University of Oxford 52
Next Page